文献速递重症综合管理与镇静镇痛心脑血管急症

心脏术后ICU患者使用高渗盐水进行液体复苏(HERACLES):一项双盲随机对照临床试验

Hypertonic saline for fluid resuscitation in ICU patients post-cardiac surgery (HERACLES): a double-blind randomized controlled clinical trial.
PubMed 文献 · Intensive Care Med · 2020-06-09
一句话结论心脏术后ICU患者单次输注7.3%高渗盐水(5 ml/kg,60分钟)未减少ICU累计液体入量,但增加尿量并降低液体平衡,电解质和酸碱变化短暂但显著。

这项前瞻性随机双盲单中心临床试验纳入101例择期瓣膜和/或冠脉心脏病心脏手术患者,比较ICU入室时单次输注7.3% NaCl(5 ml/kg,60分钟)与0.9% NaCl对围术期累计液体量的影响。主要终点ICU累计液体入量在两组间无差异(高渗盐水组中位3193 ml vs 生理盐水组3345 ml)。高渗盐水组术后至ICU出科尿量增加(中位2250 ml vs 1545 ml),ICU液体平衡更低(中位296 ml vs 1137 ml)。结论认为高渗盐水未减少ICU总液体量,但与尿量及时增加相关,电解质和酸碱变化短暂但显著。

要点

  • 心脏术后ICU入室单次输注7.3% NaCl 5 ml/kg(60分钟)未减少ICU累计液体入量(中位3193 ml vs 生理盐水组3345 ml)。
  • 高渗盐水组术后至ICU出科尿量增加(中位2250 ml vs 1545 ml),ICU液体平衡更低(中位296 ml vs 1137 ml)。
  • 电解质和酸碱平衡变化短暂但所有患者均显著。
  • 研究排除了晚期器官功能障碍、感染和/或长期使用类固醇药物的患者。
  • 该单中心随机双盲试验未发现高渗盐水减少ICU总液体量的效果。

适用人群与场景

  • 择期瓣膜和/或冠脉心脏病心脏手术患者,术后入住ICU。
  • 排除晚期器官功能障碍、感染和/或长期使用类固醇药物的患者。

处置流程与药物剂量

  • ICU入室时单次输注7.3% NaCl 5 ml/kg体重(或0.9% NaCl对照),60分钟内输完。

研究设计与关键结果

  • 研究类型:前瞻性随机双盲单中心临床试验;样本量101例(高渗盐水组53例,生理盐水组48例)。
  • 主要终点:ICU累计液体入量高渗盐水组中位3193 ml(IQR 2052-4333 ml)vs 生理盐水组3345 ml(IQR 2332-5043 ml),无差异。
  • 关键次要终点:术后至ICU出科尿量高渗盐水组中位2250 ml(IQR 1640-2690 ml)vs 生理盐水组1545 ml(IQR 1087-1976 ml);ICU液体平衡高渗盐水组中位296 ml(IQR -441至1412 ml)vs 生理盐水组1137 ml(IQR 322-2660 ml)。
  • 电解质和酸碱平衡变化短暂但所有患者均显著。

证据类型、等级与局限

  • 证据类型:前瞻性随机双盲单中心临床试验。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 对于择期心脏手术术后ICU患者,单次输注7.3% NaCl 5 ml/kg(60分钟)未减少ICU累计液体入量,但与尿量增加和液体平衡降低相关。
  • 该研究排除了晚期器官功能障碍、感染和/或长期使用类固醇药物的患者,结果不适用于这些人群。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

PURPOSE: Recent evidence questions a liberal approach to fluid resuscitation in intensive care unit (ICU) patients. Here, we assess whether use of hypertonic saline applied as single infusion at ICU admission after cardiac surgery can reduce cumulative perioperative fluid volume.

METHODS: Prospective randomized double-blind single-center clinical trial investigates effects of a single infusion of hypertonic saline (HS) versus normal saline (comparator). Primary endpoint was the cumulative amount of fluid administered in patients in the hypertonic saline versus the 0.9% saline groups (during ICU stay). Upon ICU admission, patients received a single infusion of 5 ml/kg body weight of 7.3% NaCl (or 0.9% NaCl) over 60 min. Patients undergoing cardiac surgery for elective valvular and/or coronary heart disease were included. Patients with advanced organ dysfunction, infection, and/or patients on chronic steroid medication were excluded.

RESULTS: A total of 101 patients were randomized to receive the study intervention (HS n = 53, NS n = 48). Cumulative fluid intake on the ICU (primary endpoint) did not differ between the HS and the NS groups [median 3193 ml (IQR 2052-4333 ml) vs. 3345 ml (IQR 2332-5043 ml)]. Postoperative urinary output until ICU discharge was increased in HS-treated patients [median 2250 ml (IQR 1640-2690 ml) vs. 1545 ml (IQR 1087-1976 ml)], and ICU fluid balance was lower in the HS group when compared to the NS group [296 ml (IQR - 441 to 1412 ml) vs. 1137 ml (IQR 322-2660 ml)].

CONCLUSION: In a monocentric prospective double-blind randomized clinical trial, we observed that hypertonic saline did not reduce the total fluid volume administered on the ICU in critically ill cardiac surgery patients. Hypertonic saline infusion was associated with timely increase in urinary output. Variations in electrolyte and acid-base homeostasis were transient, but substantial in all patients.

来源:Intensive Care Med,查看原文。版权归原作者所有。

参考来源

  1. Pfortmueller CA, Kindler M, Schenk N, et al. Hypertonic saline for fluid resuscitation in ICU patients post-cardiac surgery (HERACLES): a double-blind randomized controlled clinical trial. Intensive Care Med. 2020. PMID: 32519005. doi:10.1007/s00134-020-06132-0

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。